Both in Pharmaceuticals
BridgeBio Pharma vs Viatris
Over the past year BBIO returned +19.4% and VTRS returned +79.7%; their daily moves had a correlation of 0.17.
BBIO +19.4% VTRS +79.7%Growth of $1, one year, split-adjusted
| Metric | BBIO | VTRS |
|---|---|---|
| Price | $74.03 | $18.92 |
| Market cap | $14.42B | $21.73B |
| Today | −1.29% | +1.34% |
| 1 month | +11.9% | +7.4% |
| 6 months | +7.6% | +21.9% |
| Year to date | −3.2% | +52.0% |
| 1 year | +18.2% | +82.6% |
| Revenue growth (YoY) | +192.6% | +4.9% |
| Gross margin | 94.2% | 38.8% |
| Net margin | −23.5% | −3.2% |
| P/E (TTM) | — | — |
| Price / sales | 15.3× | 1.5× |
| Net cash | -$938.6M | -$12.46B |
| Dividend yield | — | 2.54% |
| Volatility (60d) | 32.4% | 23.2% |
| Short % of float | 12.5% | 3.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).